-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Vertex Pharmaceuticals Inc / Ma quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2010 to Q3 2025.
- Vertex Pharmaceuticals Inc / Ma Depreciation, Depletion and Amortization for the quarter ending September 30, 2025 was $54M, a 1.5% increase year-over-year.
- Vertex Pharmaceuticals Inc / Ma Depreciation, Depletion and Amortization for the twelve months ending September 30, 2025 was $201M.
- Vertex Pharmaceuticals Inc / Ma annual Depreciation, Depletion and Amortization for 2024 was $207M, a 14.3% increase from 2023.
- Vertex Pharmaceuticals Inc / Ma annual Depreciation, Depletion and Amortization for 2023 was $181M, a 22.3% increase from 2022.
- Vertex Pharmaceuticals Inc / Ma annual Depreciation, Depletion and Amortization for 2022 was $148M, a 18.1% increase from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)